US Biomax, Inc.

NH1001

Nasopharynx disease spectrum (nasopharynx cancer progression) tissue array, 49 cases/100 cores

Microarray Panel:Nasopharyngeal cancer tissue microarray, containing 15 cases of squamous cell carcinoma, 3 basal cell carcinoma, 2 each of adenocarcinoma and undifferentiated carcinoma, 15 papilloma, 6 polyp, 3 each of hyperplasia and inflammation, 1 adjacent normal tissue, duplicate cores per case
Cores:100
Cases:49
Layout:10 cols × 10 rows
Core Diameter:1 mm
Thickness:5 µm
Quality Control:Anti-Cytokeratin (CK) confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.


Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Nos Nos Nos Nos Nos Nos Nos Nos Nos Nos  
B Nas Nas Nos Nos Nos Nos Nos Nos Nos Nos  
C Nos Nos Nos Nos Nos Nos Nos Nos Nos Nos  
D Nos Nos Nos Nos Nos Nos Nos Nos Nos Nos  
E Nos Nos Nos Nos Nos Nos Nos Nos Nos Nos  
F Nos Nos Nos Nos Nos Nos Nos Nos Nos Nos  
G Nos Nos Nos Nos Nos Nos Nos Nos Nos Nos  
H Nos Nos Nos Nos Nos Nos Nos Nos Nos Nos  
I Nos Nos Nos Nos Nos Nos Nos Nos Nos Nos  
J Nos Nos Nos Nos Nos Nos Nos Nos Nos Nos Marked point
Legend: Nas - Nasopharyngeal, Nos - Nose

- Benign tumor, - Hyperplasia, - Inflammation, - Malignant tumor, - NAT, - Polyp

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade TNM Type †
A1 1 M 73 Nose Squamous cell carcinoma 1 T1N0M0 Malignant
A2 2 M 73 Nose Squamous cell carcinoma 1 T1N0M0 Malignant
A3 3 M 63 Nose Squamous cell carcinoma 1 T1N0M0 Malignant
A4 4 M 63 Nose Squamous cell carcinoma 1 T1N0M0 Malignant
A5 5 M 47 Nose Squamous cell carcinoma 1 T1N0M0 Malignant
A6 6 M 47 Nose Squamous cell carcinoma 1 T1N0M0 Malignant
A7 7 M 74 Nose Squamous cell carcinoma 2 T2N0M0 Malignant
A8 8 M 74 Nose Squamous cell carcinoma 2 T2N0M0 Malignant
A9 9 M 58 Nose Squamous cell carcinoma (mixed gland) T1N0M0 Malignant
A10 10 M 58 Nose Squamous cell carcinoma (mixed gland) T1N0M0 Malignant
B1 11 M 33 Nasopharyngeal Squamous cell carcinoma 2 T1N0M0 Malignant
B2 12 M 33 Nasopharyngeal Squamous cell carcinoma 2 T1N0M0 Malignant
B3 13 M 52 Nose Squamous cell carcinoma 2 T1N0M0 Malignant
B4 14 M 52 Nose Squamous cell carcinoma 2 T1N0M0 Malignant
B5 15 M 56 Nose Squamous cell carcinoma 2 T1N0M0 Malignant
B6 16 M 56 Nose Squamous cell carcinoma 2 T1N0M0 Malignant
B7 17 F 45 Nose Squamous cell carcinoma 2 T1N0M0 Malignant
B8 18 F 45 Nose Squamous cell carcinoma 2 T1N0M0 Malignant
B9 19 M 42 Nose Squamous cell carcinoma 2 T1N0M0 Malignant
B10 20 M 42 Nose Squamous cell carcinoma 2 T1N0M0 Malignant
C1 21 M 43 Nose Squamous cell carcinoma 2 T3N0M0 Malignant
C2 22 M 43 Nose Squamous cell carcinoma 2 T3N0M0 Malignant
C3 23 M 47 Nose Squamous cell carcinoma 2 T2N0M0 Malignant
C4 24 M 47 Nose Squamous cell carcinoma 2 T2N0M0 Malignant
C5 25 M 36 Nose Squamous cell carcinoma 3 T1N0M0 Malignant
C6 26 M 36 Nose Squamous cell carcinoma 3 T1N0M0 Malignant
C7 27 F 51 Nose Squamous cell carcinoma 3 T2N0M0 Malignant
C8 28 F 51 Nose Squamous cell carcinoma 3 T2N0M0 Malignant
C9 29 M 56 Nose Squamous cell carcinoma (sparse) 3 T2N0M0 Malignant
C10 30 M 56 Nose Squamous cell carcinoma 2–3 T2N0M0 Malignant
D1 31 F 56 Nose Basal cell carcinoma T1N0M0 Malignant
D2 32 F 56 Nose Basal cell carcinoma T1N0M0 Malignant
D3 33 F 84 Nose Basal cell carcinoma T1N0M0 Malignant
D4 34 F 84 Nose Basal cell carcinoma T1N0M0 Malignant
D5 35 M 65 Nose Basal cell carcinoma T1N0M0 Malignant
D6 36 M 65 Nose Basal cell carcinoma T1N0M0 Malignant
D7 37 F 68 Nose Adenoid cystic carcinoma T1N0M0 Malignant
D8 38 F 68 Nose Adenoid cystic carcinoma T1N0M0 Malignant
D9 39 M 60 Nose Adenocarcinoma 3 T1N0M0 Malignant
D10 40 M 60 Nose Adenocarcinoma (hemorrhage and necrotic tisue) T1N0M0 Malignant
E1 41 M 73 Nose Undifferentiated carcinoma T4aN0M0 Malignant
E2 42 M 73 Nose Undifferentiated carcinoma T4aN0M0 Malignant
E3 43 M 46 Nose Undifferentiated carcinoma T1N0M0 Malignant
E4 44 M 46 Nose Undifferentiated carcinoma T1N0M0 Malignant
E5 45 M 43 Nose Inverted papilloma Benign
E6 46 M 43 Nose Inverted papilloma Benign
E7 47 M 30 Nose Inverted papilloma Benign
E8 48 M 30 Nose Inverted papilloma Benign
E9 49 M 42 Nose Inverted papilloma Benign
E10 50 M 42 Nose Inverted papilloma Benign
F1 51 M 52 Nose Inverted papilloma Benign
F2 52 M 52 Nose Inverted papilloma Benign
F3 53 M 73 Nose Inverted papilloma Benign
F4 54 M 73 Nose Inverted papilloma Benign
F5 55 F 68 Nose Inverted papilloma Benign
F6 56 F 68 Nose Inverted papilloma Benign
F7 57 M 50 Nose Inverted papilloma Benign
F8 58 M 50 Nose Inverted papilloma Benign
F9 59 M 55 Nose Inverted papilloma Benign
F10 60 M 55 Nose Inverted papilloma Benign
G1 61 M 43 Nose Inverted papilloma Benign
G2 62 M 43 Nose Inverted papilloma Benign
G3 63 M 62 Nose Inverted papilloma (sparse) Benign
G4 64 M 62 Nose Inverted papilloma Benign
G5 65 M 56 Nose Inverted papilloma Benign
G6 66 M 56 Nose Inverted papilloma Benign
G7 67 F 37 Nose Inverted papilloma Benign
G8 68 F 37 Nose Inverted papilloma Benign
G9 69 F 71 Nose Inverted papilloma Benign
G10 70 F 71 Nose Inverted papilloma Benign
H1 71 M 54 Nose Inverted papilloma Benign
H2 72 M 54 Nose Inverted papilloma Benign
H3 73 M 34 Nose Inverted papilloma Benign
H4 74 M 34 Nose Inverted papilloma Benign
H5 75 M 46 Nose Polyp (chronic inflammation of fibrofatty tissue) Polyp
H6 76 M 46 Nose Polyp (chronic inflammation of fibrofatty tissue) Polyp
H7 77 M 14 Nose Polyp (fibrous tissue and blood vessel) Polyp
H8 78 M 14 Nose Polyp (fibrous tissue and blood vessel) Polyp
H9 79 M 17 Nose Polyp Polyp
H10 80 M 17 Nose Polyp Polyp
I1 81 M 69 Nose Polyp Polyp
I2 82 M 69 Nose Polyp Polyp
I3 83 M 74 Nose Polyp (fibrofatty tissue) Polyp
I4 84 M 74 Nose Polyp Polyp
I5 85 M 40 Nose Polyp (fibrous tissue and blood vessel) Polyp
I6 86 M 40 Nose Polyp Polyp
I7 87 M 42 Nose Chronic inflammation of mucosa with hyperplasia of No. 19 Hyperplasia
I8 88 M 42 Nose Chronic inflammation of mucosa with hyperplasia of No. 19 Hyperplasia
I9 89 F 45 Nose Chronic inflammation of mucosa with hyperplasia Hyperplasia
I10 90 F 45 Nose Hyperplasia (chronic inflammation of fibrous tissue and blood vessel) Hyperplasia
J1 91 F 13 Nose Chronic inflammation of mucosa with hyperplasia Hyperplasia
J2 92 F 13 Nose Chronic inflammation of mucosa with hyperplasia Hyperplasia
J3 93 M 40 Nose Chronic inflammation Inflammation
J4 94 M 40 Nose Chronic inflammation Inflammation
J5 95 M 40 Nose Chronic inflammation Inflammation
J6 96 M 40 Nose Chronic inflammation Inflammation
J7 97 M 65 Nose Chronic inflammation Inflammation
J8 98 M 65 Nose Chronic inflammation Inflammation
J9 99 M 45 Nose Cancer adjacent normal nasal tissue (fibrous tissue and blood vessel) NAT
J10 100 M 45 Nose Cancer adjacent normal nasal tissue (fibrous tissue and blood vessel) NAT
M 58 Skin Malignant melanoma (tissue marker) Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis


Find overlapping cases with this tissue array: